Abstract
In the past two decades comparative genomic hybridization (CGH) and array CGH have become crucial and indispensable tools in clinical diagnostics. Initially developed for the genome-wide screening of chromosomal imbalances in tumor cells, CGH as well as array CGH have also been employed in genotoxicology and most recently in toxicogenomics. The latter methodology allows a multi-endpoint analysis of how genes and proteins react to toxic agents revealing molecular mechanisms of toxicology. This chapter provides a background on the use of CGH and array CGH in the context of genotoxicology as well as a protocol for conventional CGH to understand the basic principles of CGH. Array CGH is still cost intensive and requires suitable analytical algorithms but might become the dominating assay in the future when more companies provide a large variety of different commercial DNA arrays/chips leading to lower costs for array CGH equipment as well as consumables such as DNA chips. As the amount of data generated with microarrays exponentially grows, the demand for powerful adaptive algorithms for analysis, competent databases, as well as a sound regulatory framework will also increase. Nevertheless, chromosomal and array CGH are being demonstrated to be effective tools for investigating copy number changes/variations in the whole genome, DNA expression patterns, as well as loss of heterozygosity after a genotoxic impact. This will lead to new insights into affected genes and the underlying structures of regulatory and signaling pathways in genotoxicology and could conclusively identify yet unknown harmful toxicants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pinkel D, Straume T, Gray JW (1986) Cytogenetic analysis using quantitative, high–sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A 83:2934–2938
Heng HH, Squire J, Tsui LC (1992) High–resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc Natl Acad Sci U S A 89:9509–9513
Speicher MR, Gwyn BS, Ward DC (1996) Karyotyping human chromosomes by combinatorial multi–fluor FISH. Nat Genet 12:368–375
Schröck E, du Manoir S, Veldman T et al (1996) Multicolor spectral karyotyping of human chromosomes. Science 273:494–497
Tanke HJ, Wiegant J, van Gijlswijk RP et al (1999) New strategy for multi–colour fluorescence in situ hybridisation: COBRA: COmbined Binary RAtio labelling. Eur J Hum Genet 7:2–11
Cremer T, Cremer C (2001) Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat Rev Genet 2:292–301
Bolzer A, Kreth G, Solovei I et al (2005) Three–dimensional maps of all chromosomes in human male fibroblast nuclei and prometaphase rosettes. PLoS Biol 3:e157
Speicher MR, Carter NP (2005) The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 6:782–792
Kallioniemi A, Kallioniemi OP, Sudar D et al (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821
du Manoir S, Speicher MR, Joos S et al (1993) Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590–610
Kallioniemi OP, Kallioniemi A, Sudar D et al (1993) Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol 4:41–46
Zitzelsberger H, Lehmann L, Werner M et al (1997) Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies. Histochem Cell Biol 108:403–417
Corso C, Parry EM (1999) The application of comparative genomic hybridization and fluorescence in situ hybridization to the characterization of genotoxicity screening tester strains AHH-1 and MCL-5. Mutagenesis 14:417–426
Carlson KM, Gruber A, Liliemark E et al (1999) Characterization of drug-resistant cell lines by comparative genomic hybridization. Cancer Genet Cytogenet 111:32–36
Corso C, Parry JM (2004) Comparative genomic hybridization analysis of N-methyl-N′-nitrosoguanidine-induced rat gastrointestinal tumors discloses a cytogenetic fingerprint. Environ Mol Mutagen 43:20–27
Payne J, Jones C, Lakhani S et al (2000) Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens. Sci Total Environ 248:51–62
Kim YM, Yang S, Xu W et al (2008) Continuous in vitro exposure to low-dose genistein induces genomic instability in breast epithelial cells. Cancer Genet Cytogenet 186:78–84
Wong N, Lai P, Pang E et al (2000) Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin Cancer Res 6:4000–4009
Clarke PA, te Poele R, Wooster R et al (2001) Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol 62:1311–1336
Solinas-Toldo S, Lampel S, Stilgenbauer S et al (1997) Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20:399–407
Ylstra B, van den Ijssel P, Carvalho B et al (2006) BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH). Nucleic Acids Res 34:445–450
Brennan C, Zhang Y, Leo C et al (2004) High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res 64:4744–4748
Chan VSW, Theilade MD (2005) The use of toxicogenomic data in risk assessment: a regulatory perspective. Clin Toxicol (Phila) 43:121–126
Amin RP, Hamadeh HK, Bushel PR et al (2002) Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology 181–182:555–563
Gerhold D, Lu M, Xu J et al (2001) Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol Genomics 5:161–170
Aradhya S, Lewis R, Bonaga T et al (2012) Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders. Genet Med 14:594–603
Wang J, Zhan H, Li F-Y et al (2012) Targeted array CGH as a valuable molecular diagnostic approach: experience in the diagnosis of mitochondrial and metabolic disorders. Mol Genet Metab 106:221–230
Hu DG, Webb G, Hussey N (2004) Aneuploidy detection in single cells using DNA array-based comparative genomic hybridization. Mol Hum Reprod 10:283–289
Fiegler H, Geigl JB, Langer S et al (2007) High resolution array-CGH analysis of single cells. Nucleic Acids Res 35:e15
Cheng J, Vanneste E, Konings P et al (2011) Single-cell copy number variation detection. Genome Biol 12:R80
Crotwell PL, Hoyme HE (2012) Advances in whole-genome genetic testing: from chromosomes to microarrays. Curr Probl Pediatr Adolesc Health Care 42:47–73
Zhao X, Li C, Paez JG et al (2004) An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64:3060–3071
Auer H, Newsom DL, Nowak NJ et al (2007) Gene-resolution analysis of DNA copy number variation using oligonucleotide expression microarrays. BMC Genomics 8:111
Le Scouarnec S, Gribble SM (2012) Characterising chromosome rearrangements: recent technical advances in molecular cytogenetics. Heredity (Edinb) 108:75–85
Schillert A, Ziegler A (2012) Genotype calling for the Affymetrix platform. Methods Mol Biol 850:513–523
Hester SD, Reid L, Nowak N et al (2009) Comparison of comparative genomic hybridization technologies across microarray platforms. J Biomol Tech 20:135–151
Herzog CR, Desai D, Amin S (2006) Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Biochem Biophys Res Commun 341:856–863
Wilkerson PM, Dedes KJ, Wetterskog D et al (2011) Functional characterization of EMSY gene amplification in human cancers. J Pathol 225:29–42
Soucek K, Gajdusková P, Brázdová M et al (2010) Fetal colon cell line FHC exhibits tumorigenic phenotype, complex karyotype, and TP53 gene mutation. Cancer Genet Cytogenet 197:107–116
Medlin JF (1999) Timely toxicology. Environ Health Perspect 107:A256–A258
Heinloth AN, Shackelford RE, Innes CL et al (2003) ATM-dependent and -independent gene expression changes in response to oxidative stress, gamma irradiation, and UV irradiation. Radiat Res 160:273–290
Heinloth AN, Shackelford RE, Innes CL et al (2003) Identification of distinct and common gene expression changes after oxidative stress and gamma and ultraviolet radiation. Mol Carcinog 37:65–82
Annereau JP, Szakács G, Tucker CJ et al (2004) Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol Pharmacol 66:1397–1405
Castagnola P, Malacarne D, Scaruffi P et al (2011) Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue. BMC Cancer 11:445
Fujimoto J, Kadara H, Men T et al (2010) Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice. PLoS One 5:e11847
Auerbach SS, Shah RR, Mav D et al (2010) Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning. Toxicol Appl Pharmacol 243:300–314
Iwahashi H, Kitagawa E, Suzuki Y et al (2007) Evaluation of toxicity of the mycotoxin citrinin using yeast ORF DNA microarray and Oligo DNA microarray. BMC Genomics 8:95
Huang Y, Fernandez SV, Goodwin S et al (2007) Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res 67:11147–11157
Milan M, Coppe A, Reinhardt R et al (2011) Transcriptome sequencing and microarray development for the Manila clam, Ruditapes philippinarum: genomic tools for environmental monitoring. BMC Genomics 12:234
Guha S, Li Y, Neuberg D (2008) Bayesian hidden markov modeling of array CGH data. J Am Stat Assoc 103:485–497
Shah SP, Xuan X, DeLeeuw RJ et al (2006) Integrating copy number polymorphisms into array CGH analysis using a robust HMM. Bioinformatics 22:e431–e439
OECD (2009) Series on testing and assessment no. 100 – Report of the second survey on available omics tools (ENV/JM/MONO(2008)35). Available at http://search.oecd.org/officialdocuments/displaydocumentpdf/?cote=env/jm/mono%282008%2935&doclanguage=en
Mahadevan B, Snyder RD, Waters MD et al (2011) Genetic toxicology in the 21st century: reflections and future directions. Environ Mol Mutagen 52:339–354
Aardema MJ, MacGregor JT (2002) Toxicology and genetic toxicology in the new era of ‘toxicogenomics’: impact of ‘-omics’ technologies. Mutat Res 499:13–25
Vrana KE, Freeman WM, Aschner M (2003) Use of microarray technologies in toxicology research. Neurotoxicology 24:321–332
Ge F, He QY (2009) Genomic and proteomic approaches for predicting toxicity and adverse drug reactions. Expert Opin Drug Metab Toxicol 5:29–37
Mattingly CJ, Rosenstein MC, Davis AP et al (2006) The comparative toxicogenomics database: a cross-species resource for building chemical–gene interaction networks. Toxicol Sci 92:587–595
Davis AP, King BL, Mockus S et al (2011) The comparative toxicogenomics database: update 2011. Nucleic Acids Res 39:D1067–D1072
Young RR (2002) Genetic toxicology: web resources. Toxicology 173:103–121
Jacobs A (2009) An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs. Toxicol Lett 186:32–35
Nuwaysir EF, Bittner M, Trent J et al (1999) Microarrays and toxicology: the advent of toxicogenomics. Mol Carcinog 24:153–159
Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council (2007) Toxicity testing in the 21st century: a vision and a strategy. The National Academies Press, Washington, DC
Andersen ME, Al-Zoughool M, Croteau M et al (2010) The future of toxicity testing. J Toxicol Environ Health B Crit Rev 13:163–196
Krewski D, Westphal M, Al-Zoughool M et al (2011) New directions in toxicity testing. Annu Rev Public Health 32:161–178
Bhattacharya S, Zhang Q, Carmichael PL et al (2011) Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways. PLoS One 6:e20887
Gatzidou ET, Zira AN, Theocharis SE (2007) Toxicogenomics: a pivotal piece in the puzzle of toxicological research. J Appl Toxicol 27:302–309
Harrill AH, Rusyn I (2008) Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity. Expert Opin Drug Metab Toxicol 4:1379–1389
Zhang Q, Bhattacharya S, Andersen ME et al (2010) Computational systems biology and dose–response modeling in relation to new directions in toxicity testing. J Toxicol Environ Health B Crit Rev 13:253–276
Grant GR, Manduchi E, Stoeckert CJ Jr (2007) Analysis and management of microarray gene expression data. Curr Protoc Mol Biol 19:Unit 19.6
Vermeesch JR, Melotte C, Froyen G et al (2005) Molecular karyotyping: array CGH quality criteria for constitutional genetic diagnosis. J Histochem Cytochem 53:413–422
Shaw-Smith C, Redon R, Rickman L et al (2004) Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet 41:241–248
Brazma A (2009) Minimum Information About a Microarray Experiment (MIAME)-successes, failures, challenges. Scientific World Journal 9:420–423
Taylor RC, Acquaah-Mensah G, Singhal M et al (2008) Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress. PLoS Comput Biol 4:e1000166
Telenius H, Carter NP, Bebb CE et al (1992) Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13:718–725
Zhang L, Cui X, Schmitt K et al (1992) Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci U S A 89:5847–5851
du Manoir S, Kallioniemi OP, Lichter P et al (1995) Hardware and software requirements for quantitative analysis of comparative genomic hybridization. Cytometry 19:4–9
du Manoir S, Schröck E, Bentz M et al (1995) Quantitative analysis of comparative genomic hybridization. Cytometry 19:27–41
Piper J, Rutovitz D, Sudar D et al (1995) Computer image analysis of comparative genomic hybridization. Cytometry 19:10–26
Lundsteen C, Maahr J, Christensen B et al (1995) Image analysis in comparative genomic hybridization. Cytometry 19:42–50
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Baumgartner, A. (2013). Comparative Genomic Hybridization (CGH) in Genotoxicology. In: Dhawan, A., Bajpayee, M. (eds) Genotoxicity Assessment. Methods in Molecular Biology, vol 1044. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-529-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-62703-529-3_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-528-6
Online ISBN: 978-1-62703-529-3
eBook Packages: Springer Protocols